tbuckley/cabot-search huggingface dataset:
pulse
Journal: JAMA (1989)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Reply
Authors: Victoria M. Yates, Rebecca E.I. Kerr, Rona M. MacKie
Journal: British Journal of Dermatology (1983)

Journal Article Reply Get access Victoria M. Yates, Victoria M. Yates Dept. of Dermatology, Anderson College Building, University of Glasgow, Glasgow G11 6NU Search for other works by this author on: Oxford Academic Google Scholar Rebecca E.I. Kerr, Rebecca E.I. Kerr Dept. of Dermatology, Anderson College Building, University of Glasgow, Glasgow G11 6NU Search for other works by this author on: Oxford Academic Google Scholar Rona M. MacKie Rona M. MacKie Dept. of Dermatology, Anderson College Building, University of Glasgow, Glasgow G11 6NU Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 109, Issue 6, 1 December 1983, Page 722, https://doi.org/10.1111/j.1365-2133.1983.tb00558.x Published: 01 December 1983
Electroenceph &amp;amp; Clin Neurophysiol, Amsterdam
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
High resolution computed tomography as a predictor of lung histology in systemic sclerosis
Authors: A U Wells, D M Hansell, B Corrin, N K Harrison, P Goldstraw, C M Black, R M du Bois
Journal: Thorax (1992)

<i>Background</i> The relative proportions of fibrosis and inflammation seen by open lung biopsy examination is a predictor of disease outcome in fibrosing alveolitis. This study was designed to assess the ability of high resolution computed tomography to predict the histological appearance of open lung biopsy specimens from patients with systemic sclerosis. <i>Methods</i> Twenty abnormal biopsy specimens from 12 patients were assessed; abnormalities were categorised as fibrotic (fibrosis exceeding inflammation) or inflammatory (inflammation equal to or exceeding fibrosis). Computed tomography appearances were scored for the lobe from which the biopsy specimen was taken; scans were graded from parenchymal opacification alone through to a reticular pattern alone. <i>Results</i> Two lobar appearances were identified on computed tomograms: amorphous parenchymal opacification equal in extent to reticulation (grade 3) and a predominantly reticular pattern (grade 4). There was a significant association between a fibrotic histological appearance and a grade 4 computed tomogram, and between an inflammatory histological appearance and a grade 3 computed tomogram. Computed tomography grade 4 was associated with a fibrotic histological appearance in 12 out of 13 lobes, and grade 3 with an inflammatory histological appearance in four out of seven lobes. <i>Conclusion</i> Computed tomography discriminated between biopsy specimens that were predominantly fibrotic and a smaller group with a larger amount of inflammation.
Extracorporeal Removal Of Drugs And Poisons By Hemodialysis And Hemoperfusion
Authors: R. Cutler
Journal: The Annual Review of Pharmacology and Toxicology (1987)

Heme oxygenases (HO) catabolize free heme, that is, iron (Fe) protoporphyrin (IX), into equimolar amounts of Fe2+, carbon monoxide (CO), and biliverdin. The stress-responsive HO-1 isoenzyme affords protection against programmed cell death. The mechanism ...Read More
Low-dose Methotrexate May Cause Air Trapping in Patients with Rheumatoid Arthritis
Authors: Charles S. Dayton, David A. Schwartz, Nancy L. Sprince, Stephen J. Yagla, Charles S. Davis, Raechelle K. Koehnke, Daniel E. Furst, Gary W. Hunninghake
Journal: American Journal of Respiratory and Critical Care Medicine (1995)

Both rheumatoid arthritis (RA) and methotrexate (MTX) are reported to be associated with the development of pulmonary disease. To determine whether MTX enhanced the risk of developing abnormalities in pulmonary function in patients with RA, we prospectively studied 31 subjects (12 male, 19 female) with the diagnosis of classic RA for an average period of 4.4 yr (range, 1 to 5 yr). Each subject was placed on low-dose weekly MTX (mean 17 mg, range 2.5 to 40) for control of RA symptoms. Other medications included non-steroidal anti-inflammatory agents and prednisone if required for control of arthritis symptoms. No other immunosuppressive therapy was used. Each subject was evaluated by pulmonary function tests (PFT) and chest X-ray initially, and at 1, 2, 3.5, and 5 yr. Chest X-rays obtained initially and at the end of the study period were found to be normal. The percent predicted values for initial PFTs in the study group were within the normal range. From the beginning to the end of the observation period, the following mean changes in lung function were observed: 1.9% increase in TLC, 5.1% increase in residual volume (RV), 1.8% increase in FVC, 0.71% decrease in FEV1, 14.7% improvement in alveolar-arterial oxygen (A-aO2) difference, and a 12.7% increase in single-breath diffusing capacity (DlCO). To determine whether MTX (average dose, weekly dose, or cumulative dose) was significantly related to changes in pulmonary function, we used multivariate techniques to control for the initial measure of lung function while assessing the relationship between MTX and the subsequent measures of lung function. In addition, we controlled for age, sex, height, follow-up time, pack-years of cigarette smoking, and cumulative prednisone dosage. Our results indicate that the cumulative dose of MTX is independently related to small, but significant, increases in residual volume. Interestingly, the dose of corticosteroids was unrelated to changes in pulmonary function during the period of observation. These findings indicate that low-dose MTX may cause mild degrees of air trapping in patients with RA, however, it does not appear to cause restrictive lung function or abnormalities in gas exchange.
Competency to give an informed consent. A model for making clinical assessments
Authors: J. F. Drane
Journal: JAMA (1984)

A patient's decision must be informed and free, and he/she must be competent either to consent to or refuse treatment. Rather than selecting a single standard of competency, a sliding scale is suggested that requires an increasingly more stringent standard as the consequences of the patient's decision embody more risk. The standard of competency to consent to or to refuse treatment depends on the dangerousness of the treatment decision. Three different standards are correlated with the psychiatric abnormalities that are most likely to undermine them. A model with guidelines for use is provided to aid the physician who is called on to make a determination of competency. (<i>JAMA</i>1984;252:925-927)
Uncle George
Journal: JAMA (1983)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Harefuah, Tel-Aviv
Journal: JAMA (1965)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Research on vitamin-cancer relationship getting big boost
Journal: JAMA (1982)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The past, present, and future of continuing medical education. Achievements and opportunities, computers and recertification
Authors: P. R. Manning
Journal: JAMA (1987)

Changes in continuing medical education (CME) during the past three decades have been controversial and complex. A 1950s-style, small-scale, voluntary activity has evolved, in 1987, into broad-scale programs with accredited sponsors and with ties to relicensure. Within the next three decades, CME will be directed by methods chosen by specialty boards for recertification and by exploitation of computer and telecommunication technology. Written recertification examinations can waste physicians' time studying material that will not improve care of their patients. We hope improved methods of analysis of individual practices, on-the-spot access to pertinent medical information, and better communication among physicians can be incorporated into recertification procedures. Policies established now will shape CME for decades to come. We encourage a coordinated effort by medical specialty boards, medical societies, hospitals, medical schools, computer corporations, telecommunication firms, granting agencies, and the National Library of Medicine to ensure the most effective and efficient recertification and CME policies. (<i>JAMA</i>1987;258:3542-3546)
MALARIAL INFECTION IN CERTAIN NATIVE VILLAGES OF THE CANAL ZONE.
Authors: ARTHUR I. KENDALL
Journal: JAMA (1906)

When a body of men is sent to occupy a foreign country for any purpose, one of the first tasks of the sanitary authorities is to investigate and take precautions against the prevailing infectious diseases. The American occupancy of certain portions of the Isthmus of Panama was inaugurated by an investigation of the malarial fevers, for which this region has long been famous, and the results of this investigation form the basis of this paper. In October, 1904, I was detailed to visit certain native villages, examine as many natives as might be necessary to insure accuracy of results, and to report on the percentage of inhabitants whose peripheral circulation harbored malarial parasites. The object of this work was not so much to determine the actual number of sick<i>per se</i>, but to include in the statistics indiscriminately the population of a certain area, noting just what proportion of the
From Hooper to Hohensee. Some highlights of American patent medicine promotion
Authors: J. H. Young
Journal: JAMA (1968)

Surveying the historical development of patent medicine advertising, a commentator once concluded: "There has been no evolution; the medical advertisement sprang into existence fully matured." In one sense, perhaps, this historian was right. Building on centuries of oral harangues by itinerant pitchmen, the first printed advertisements could take advantage of time-tested appeals to the credulous. In the 17th and 18th centuries, handbills and newspaper promotion displayed remarkable ingenuity in manipulating the fears and hopes which move a suffering humanity. In another sense, if we take American nostrum history as an example, there has been change. Six main periods can be designated. First are the years of colonial subservience to the mother country, years of "immaturity and imitation." Next, in the decades following the Revolution, American medicine makers declare their independence: nostrums are "proud and patriotic." Third, in the vigor of westward expansion and the exaltation of the common man, patent
Laboratory Investigation, New York
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Clinics in Rheumatic Diseases Vol. 8. No. 1. Systemic Lupus Erythematosus
Authors: P. Hollingworth
Journal: Annals of the Rheumatic Diseases (1984)

Bilharzial arthropathy 809Finally, we propose clinical criteria for the diagnosis of bilharzial arthropathy: the identification of bilharzial ova or granulomatous changes in any organ of the human body after exposure to bilharzial infection; involvement of one or more large joints of an inflammatory character without effusion, de- formity, or loss of joint function; histopathological evidence of reactive synovitis, vasculitis with or without the presence of bilharzial ova in the synovial biopsy of a joint; negative RF, slightly or moder- ately raised ESR, and pus cells in urine; reactive inflammatory x-ray changes in the heels or sacroiliac joints.
BLOOD BANKING PROBLEMS
Journal: JAMA (1967)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
针对外周血管畸形的国际核心指标集的开发(OVAMA项目)
Authors: S.E.R. Horbach, C.M.A.M. van der Horst, F. Blei, C.J.M. van der Vleuten, I. J. Frieden, G.T. Richter, S.T. Tan, T. Muir, A.J. Penington, L.M. Boon, P.I. Spuls
Journal: British Journal of Dermatology (2018)

外周血管畸形(VM)是指由在胚胎中形成的血管发育缺陷而导致的胎记或肿胀。不同的类型可根据其主要组成部分来分类:分为淋巴管(LM)、血管(VM)或结合动脉和血管(AVM)。目前难以评估现有的各种医疗和外科手术治疗方法,因为医学界尚没有衡量结果指标的统一方法。该国际组织针对医务人员和患者开展了一项在线调查,以决定未来的临床试验中需要重点记录的因素。他们首先列出了病情及其疗法的各种方面,涉及36个领域共97个具体项目。随后,他们邀请了167名医生和134名患者及患者父母对这些项目进行打分,从0(不重要)到4(至关重要)。经过3轮调查和共识会议之后,选项范围逐渐缩小。最终达成一致的“核心指标集”涵盖:扫描结果;医生对由VM压力引起的问题的评估;患者或父母对症状、疼痛和生活质量的评估;以及他们对治疗、结果和任何副作用的满意程度。针对LM的其他具体因素为感染和淋巴液漏;针对VM的为血栓症,而针对AVM的则为心脏功能和出血。相关人员还建议将治疗后复发和外观纳入指标范围。这项国际共识确立了需要在将来的血管畸形治疗试验中进行评估的因素,但还需要进一步的工作来决定究竟应如何衡量和报告这些因素。
YUGOSLAVIA
Journal: JAMA (1962)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
Authors: Steve R. Ommen, Seema Mital, Michael A. Burke, Sharlene M. Day, Anita Deswal, Perry Elliott, Lauren L. Evanovich, Judy Hung, José A. Joglar, Paul Kantor, Carey Kimmelstiel, Michelle Kittleson, Mark S. Link, Martin S. Maron, Matthew W. Martinez, Christina Y. Miyake, Hartzell V. Schaff, Christopher Semsarian, Paul Sorajja
Journal: Journal of the American College of Cardiology (2020)